***Background.*** The use of contact precautions (CP) to control multidrug-resistant organisms (MDROs) is a patient-unfriendly strategy that has been shown to impede patient care. We hypothesized that the need for CP could be reduced by improving hand hygiene compliance. After hand hygiene compliance rates exceeded 85% for four years, we decided to scale back the use of CP.

***Methods.*** VCU Medical Center is an 865-bed, urban, academic medical center with 8 intensive care units (152 beds) and 25 ward units. Over the past decade, our infection prevention strategies have been primarily horizontal (aggressive hand hygiene compliance monitoring, bare below the elbows approach, chlorhexidine bathing, and care bundles), with active surveillance for MRSA only conducted in our neonatal ICU. Hospital-wide concurrent surveillance for device-associated infections is performed using NHSN methods and case definitions. Historically, all patients known to be infected or colonized with MDROs were placed in CP. From April 1, 2013 onward, patients infected or colonized with MRSA or VRE were placed in contact precautions only if they had wound drainage not contained within a dressing or uncontained respiratory secretions. On the first day of the new isolation protocol, 53 patients were released from CP. We compared device-associated MRSA infection rates for the time periods one year prior to and one year after de-escalation of CP.

          4/1/12--3/31/13   4/1/13--3/31/14   *P*                           
  ------- ----------------- ----------------- ------- --- --------- ------- ------
  Ward    10                159,482           0.063   6   164,414   0.036   0.29
  ICU     3                 42,021            0.071   3   44,069    0.068   0.95
  Total   13                201,503           0.065   9   208,483   0.043   0.35

***Conclusion.*** Discontinuation of CP for MRSA infection and colonization had no impact on MRSA device-associated infection rates. Hospitals with high levels of hand hygiene compliance might consider a similar strategy.
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